We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
-1.16%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$80.1B
AUM Growth
-$1.7B
(-2.1%)
Cap. Flow
+$2.19B
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
21.16%
Holding
1,667
New
254
Increased
358
Reduced
527
Closed
517
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.23B |
| 2 |
Gilead Sciences
GILD
|
+$880M |
| 3 |
Canadian Natural Resources
CNQ
|
+$844M |
| 4 |
AbbVie
ABBV
|
+$547M |
| 5 |
Shell
SHEL
|
+$531M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$762M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$529M |
| 3 |
Costco
COST
|
+$504M |
| 4 |
HP
HPQ
|
+$502M |
| 5 |
Cisco
CSCO
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 20.66% |
| 3 | Consumer Discretionary | 10.34% |
| 4 | Financials | 9.66% |
| 5 | Energy | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Zebra Technologies
ZBRA
$18B
| $51.2M | 0.06% |
123,670
-320,395
| -72% | -$147M |
|
252
Encompass Health
EHC
$12.5B
| $50.8M | 0.06% |
897,718
+63,822
| +8% | +$3.33M |
|
253
Concentrix
CNXC
$1.56B
| $50.7M | 0.06% |
304,314
-57,737
| -16% | -$11M |
|
254
Boyd Gaming
BYD
$6.04B
| $50.3M | 0.06% |
764,611
-380,699
| -33% | -$24.7M |
|
255
Brixmor Property Group
BRX
$9.14B
| $49.4M | 0.06% |
1,912,257
-365,759
| -16% | -$9.24M |
|
256
United Microelectronic
UMC
$48.1B
| $48.6M | 0.06% |
5,329,475
-1,003,829
| -16% | -$9.95M |
|
257
MongoDB
MDB
$35B
| $48.1M | 0.06% |
108,486
+18,373
| +20% | +$7.18M |
|
258
Gartner
IT
$11.8B
| $47.7M | 0.06% |
160,408
-9,993
| -6% | -$2.89M |
|
259
Bio-Rad Laboratories Class A
BIO
$9.41B
| $47.4M | 0.06% |
84,108
+1,701
| +2% | +$1.03M |
|
|
WCC
260
WESCO International
WCC
$18.1B
| $47M | 0.06% |
360,903
+126,489
| +54% | +$15.8M |
|
261
TransUnion
TRU
$15.2B
| $46.1M | 0.06% |
445,668
+158,102
| +55% | +$16M |
|
262
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $45.9M | 0.06% |
101,552
-25,387
| -20% | -$11.3M |
|
263
Tenaris
TS
$27.1B
| $45.8M | 0.06% |
1,523,751
+1,481,638
| +3,518% | +$38.5M |
|
264
Hershey
HSY
$36.4B
| $45.4M | 0.06% |
209,802
-425,576
| -67% | -$86.4M |
|
265
POSCO
PKX
$17.3B
| $45M | 0.06% |
759,597
-97,297
| -11% | -$5.74M |
|
266
Manhattan Associates
MANH
$11.5B
| $44.7M | 0.06% |
321,947
-331,315
| -51% | -$44.4M |
|
267
Centene
CNC
$32.8B
| $44.4M | 0.06% |
+526,938
| New | +$43.2M |
|
268
Columbia Sportswear
COLM
$2.94B
| $44.3M | 0.06% |
488,797
-300,285
| -38% | -$27.8M |
|
269
RELX
RELX
$61.7B
| $42.9M | 0.05% |
1,378,055
+370,016
| +37% | +$11.2M |
|
270
Red Rock Resorts
RRR
$3.71B
| $42.7M | 0.05% |
880,300
+18,672
| +2% | +$890K |
|
271
Blackrock
BLK
$177B
| $42.7M | 0.05% |
55,850
+52,306
| +1,476% | +$40.9M |
|
272
Alcon
ALC
$36.7B
| $42.5M | 0.05% |
+533,821
| New | +$41.3M |
|
|
SNP
273
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $42.3M | 0.05% |
854,651
-29,878
| -3% | -$1.5M |
|
274
Western Midstream Partners
WES
$19.8B
| $42.2M | 0.05% |
1,672,718
-396,224
| -19% | -$9.77M |
|
275
Keysight
KEYS
$58.2B
| $42.1M | 0.05% |
266,229
-1,464,884
| -85% | -$244M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Arrowstreet Capital held 1,667 positions worth $80.1B, down 2.1% from $81.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital's Q1 2022 filing shows 254 new, 358 increased, 527 reduced and 517 closed positions. Its largest new stake was Canadian Natural Resources: 31,676,509 shares worth $961M. The largest sale was NVIDIA, an estimated $762M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Arrowstreet Capital's largest Q1 2022 buy was Canadian Natural Resources: 31,676,509 shares worth $961M.
- Arrowstreet Capital added most to UnitedHealth in Q1 2022, an estimated $1.23B increase.
- Arrowstreet Capital's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $762M.
- Arrowstreet Capital fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $529M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $80.1B portfolio in Q1 2022.
- Arrowstreet Capital opened 254 new positions and closed 517 in Q1 2022.
- Arrowstreet Capital's portfolio value fell 2.1% quarter-over-quarter to $80.1B.
Based on Arrowstreet Capital's 13F filing for Q1 2022, filed 13 May 2022.